Search results
Results From The WOW.Com Content Network
In the early 1960s in Psychedelic Research Institute in Prague, Czechoslovakia, Stanislav Grof tested the value of LSD in treatment of psychologically ill patients. His goal was to observe the effect of psychedelics on the psychology of terminally-ill cancer patients. [3] Grof would later be involved in research at the Spring Grove Clinic.
The psychedelic therapy method was initiated by Humphry Osmond and Abram Hoffer (with some influence from Al Hubbard) and replicated by Keith Ditman, [90] [91] and is more closely aligned to transpersonal psychology than to traditional psychoanalysis. [citation needed] Most recent research on psychedelic therapy has used psilocybin or ayahuasca ...
Psychedelic therapy (or psychedelic-assisted therapy) refers to the proposed use of psychedelic drugs, such as psilocybin, MDMA, [note 2] LSD, and ayahuasca, to treat mental disorders. [ 58 ] [ 59 ] As of 2021, psychedelic drugs are controlled substances in most countries and psychedelic therapy is not legally available outside clinical trials ...
Psilocybin therapy is the use of psilocybin (the psychoactive ingredient in psilocybin mushrooms) in treating a range of mental health conditions, such as depression, anxiety, addictions, [1] obsessive compulsive disorder (OCD), and psychosis. [2] It is one of several forms of psychedelic therapy under study.
The Harvard Psilocybin Project was a series of experiments aimed at exploring the effects of psilocybin intake on the human mind conducted by Timothy Leary and Richard Alpert. The founding board of the project consisted of Leary, Aldous Huxley , David McClelland (Leary's and Alpert's superior at Harvard University ), [ 1 ] Frank Barron , Ralph ...
NEW YORK (AP) — It was a landmark moment for the psychedelic movement: The Department of Veteran Affairs’ top doctor stood on stage, praising advocates who have spent decades promoting the ...
The new research is part of a global movement exploring whether psychedelic-assisted therapy — including therapy using ketamine and psilocybin, the active component in magic mushrooms — can be ...
These negative effects were reported to be easily managed by the researchers and did not have a lasting negative effect on the subject's sense of well-being. [105] A follow-up study conducted 14 months after the original psilocybin session confirmed that participants continued to attribute deep personal meaning to the experience.